MedTrace Logo

Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil

NCT02110732 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-06-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the effect of oral administration of probiotic Lactobacillus rhamnosus GG in middle ear and adenoid tonsil.

Conditions

  • Upper Respiratory Infection
  • Acute Otitis Media

Interventions

DIETARY_SUPPLEMENT

Lactobacillus rhamnosus GG

Sponsors & Collaborators

  • Finnish Institute for Health and Welfare

    collaborator OTHER_GOV

  • Helsinki University Central Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-05-31
Completion
2011-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02110732 on ClinicalTrials.gov